Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)

Clinical trial NCT04730635 · COMPLETED

Trial details

NCT number: NCT04730635
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease Mild Cognitive Impairment

Start date: 2021-03-23
Primary completion: 2023-01-20
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.